Sonida Senior Living, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US1404752032
USD
30.30
-0.23 (-0.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sonida Senior Living, Inc. stock-summary
stock-summary
Sonida Senior Living, Inc.
Pharmaceuticals & Biotechnology
Capital Senior Living Corporation is an operator of senior housing communities in the United States. The Company provides senior living services to the elderly, including independent living and assisted living services, and provides home care services at one of its communities. Its continuum of care integrates independent living and assisted living and is bridged by home care through independent home care agencies or its home care agency, sustains residents' autonomy and independence based on their physical and mental abilities. It operates 105 senior housing communities in 22 states with an aggregate capacity of approximately 9000 residents. It also operates one home care agency. It offers assisted living care and services, including personal care services, around the clock staffing, support services and supplemental services.
Company Coordinates stock-summary
Company Details
14160 Dallas Pkwy Ste 300 , DALLAS TX : 75254-4383
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 14 Schemes (4.0%)

Foreign Institutions

Held by 18 Foreign Institutions (6.83%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Reid
Independent Chairman of the Board
Ms. Kimberly Lody
President, Chief Executive Officer, Director
Mr. Philip Brooks
Independent Director
Mr. Ed Grier
Independent Director
Dr. E. Rodney Hornbake
Independent Director
Ms. Jill Krueger
Independent Director
Mr. Ross Levin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
94 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 489 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.32

stock-summary
Return on Equity

-42.49%

stock-summary
Price to Book

4.53